DUBLIN--(BUSINESS WIRE)--The "Global & US Gene Therapy Market Forecast to 2020" report has been added to ResearchAndMarkets.com's offering.
According to the report, most of the gene therapy researches are being focused on finding the treatment for cancer, followed by genetic diseases and neurological disorders, respectively. In this context, the gene therapy application chapter of the report provides a comprehensive overview of various diseases in which the gene therapy is used, along with the current and future market size of gene therapy for particular disease and its geographical break up.
The major part of the revenue of gene therapy market is generated from the research phase. Most of the gene therapy products are in research phases, only few products have been commercialized till date. The report also provides the sales of major marketed gene therapy products, and the list of the products in clinical/pre-clinical research along with their clinical phases.
North America continues to have the maximum number of clinical trials in the gene therapy segment. This is a major reason for the dominant position of North America in the gene therapy market.
Key Topics Covered:
1. Research View
2. Research Methodology
3. Gene Therapy - An Introduction
4. Industry Overview
5. Clinical Trial Assessment & Pipeline Analysis
6. Gene Therapy Market - Regulatory Landscape & Reimbursement Scenario
7. Marketed Gene Therapies
8. Gene Therapy Market
9. Gene Therapy Market by Application
10. Gene Therapy Market Size by Geography
11. Competitive Landscape
12. Key Players Analysis
- Companies Mentioned
- Advantagene Inc.
- Bluebird Bio
- Human Stem Cells Institute
- Oxford BioMedica Plc
- Shanghai Sunway Biotech Co. Ltd.
- Sibiono GeneTech Co. Ltd.
- Spark Therapeutics, LLC
- uniQure N.V.
- Vical Inc.
- ViroMed Co. Ltd. dba VM BioPharma
For more information about this report visit https://www.researchandmarkets.com/research/tkqxw5/global_and_us?w=4.